ATLANTA, Jan. 18, 2022 /PRNewswire/ -- CryoLife, Inc.
(NYSE: CRY), a leading cardiac and vascular surgery company focused
on aortic disease, announced today that it was renaming and
rebranding itself to Artivion, Inc., effective immediately. Derived
from the words "aorta", "innovation", and "vision", the company's
new name and brand reflect its evolution to focus on providing
innovative technologies to surgeons who treat patients with aortic
disease. In conjunction with these changes, effective January 24, 2022, the company will also change
its ticker symbol on the New York Stock Exchange to "AORT" from
"CRY."
"Through a combination of legacy products and strategic
acquisitions and divestitures over the last five years, we have
transformed from a tissue and adhesives focused company to one with
a premier portfolio of aortic products," said Pat Mackin, Chairman, President and Chief
Executive Officer of Artivion. "Today marks an important milestone
for our company. We look forward to embarking on our next chapter
as a leader in developing simple, elegant solutions to address
cardiac and vascular surgeons' most difficult clinical challenges
in treating patients with aortic disease."
Artivion will discuss its business, its strategy, and the
rebrand at an Investor & Analyst Day on March 23, 2022, in New York City. Details of
the event will be provided at a later date.
About Artivion, Inc.
Headquartered in suburban Atlanta,
Georgia, Artivion, Inc. (Artivion) is a medical device
company focused on developing simple, elegant solutions that
address cardiac and vascular surgeons' most difficult clinical
challenges in treating patients with aortic diseases. This
multinational company's four major groups of products include:
aortic stents and stent grafts, prosthetic heart valves,
cryopreserved cardiac and vascular allografts, and surgical
sealants. Artivion markets and sells products in more than 100
countries worldwide. For additional information about Artivion,
visit our website, www.artivion.com, accessible by the end of day
today.
Contacts:
CryoLife
D. Ashley
Lee
Executive Vice President, Chief Financial
Officer and Chief Operating
Officer Phone:
770-419-3355
|
Gilmartin Group
LLC Brian Johnston / Lynn
Lewis Phone:
631-807-1986 investors@cryolife.com
|
View original content to download
multimedia:https://www.prnewswire.com/news-releases/cryolife-announces-corporate-rebranding-and-changes-name-to-artivion-301462581.html
SOURCE CryoLife, Inc.; Artivion, Inc.